
Madrigal Pharmaceuticals Announces Strong Q3 2024 Results and Strategic Advances
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has reported its financial and operational achievements for the third quarter of 2024, highlighting robust net sales and strategic progress with its …
Madrigal Pharmaceuticals Announces Strong Q3 2024 Results and Strategic Advances Read More